04/24/2026 | Press release | Archived content
For a company like TetraScience, proximity is central to the operating model. The company's approach depends on close collaboration with life sciences organizations as they translate scientific data into real AI applications. TetraScience describes its Sciborgs as scientist-engineers working at the intersection of science, data and AI, embedding with pharma teams to accelerate adoption and change.
The Basel Area offers that closeness in unusually high concentration. The region brings together more than 800 life sciences companies, over 1,000 research groups and about 33,000 professionals across biotech, pharma, medtech and healthtech.
It is the largest and most concentrated life sciences hub in mainland Europe, with global pharma leaders, specialized suppliers, research institutions and innovation infrastructure all within a compact geographic area. For companies that depend on high-value interactions and fast iteration, that density creates the conditions for faster learning, stronger partnerships and more direct access to opportunity.
Scientific AI advances through real scientific contexts, real workflows and sustained collaboration between technical and domain experts. In the Basel Area, those conditions are concentrated within one interconnected ecosystem.